"The lawyers most likely to flourish in the years ahead are those who both are adept at making wise use of AI capabilities ...

Fossil fuels will continue to play a dominant role in meeting India's energy needs over the next 10-15 years, with biofuels and other alternative energy sources expected to complement rather than ...

Detailed price information for Arcutis Biotherapeutics Inc (ARQT-Q) from The Globe and Mail including charting and trades.

EMERGE is a global, randomized, multicenter, placebo-controlled Phase 3 trial that will evaluate claseprubart 300mg/2mL S.C. dosed Q2W and Q4W vs. placebo, with top-line results anticipated in 2H'28 ...

Advancing a neuromuscular franchise with claseprubart, a highly potent investigational classical pathway inhibitor, across generalized Myasthenia Gravis (gMG), Multifocal Motor Neuropathy (MMN) and ...